Back

Medscape, LLC

  • Carcinoma, Non-Small-Cell Lung
  • Immunotherapy

Immunotherapy in Advanced NSCLC: Navigating Individualized Approaches Through Evidence and Experience

The goal of this activity is for learners to be better able to integrate the latest evidence from key immunotherapy trials into individualized, interprofessional treatment planning for advanced NSCLC, ensuring optimal patient outcomes across histologies and clinical scenarios.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Sep 17, 2026
  • Last day to claim credit
    Sep 18, 2027 11 months left